PREDICT.

Slides:



Advertisements
Similar presentations
The Drug Discovery Process
Advertisements

Drug Research and Development (R&D) Karol Godwin DVM.
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Biological pathway and systems analysis An introduction.
S TRUCTURAL B IOINFORMATICS. A subset of Bioinformatics concerned with the of biological structures - proteins, DNA, RNA, ligands etc. It is the first.
Stefan Franzén Introduction to clinical trials.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Drug Development.
Stages of drug development
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Knowledgebase Creation & Systems Biology: A new prospect in discovery informatics S.Shriram, Siri Technologies (Cytogenomics), Bangalore S.Shriram, Siri.
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Stefan Franzén Introduction to clinical trials.
Biomedical Research.
ONCOLOGY Drug Development Fadi Sami Farhat, MD ONCOLOGY Drug Development Fadi Sami Farhat, MD Hematology Oncology
Concepts and Applications of Pharmacokinetics
CPTR Overview CPTR 2012 Workshop October 2-4, 2012.
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
More than 90% compounds entering clinical trials fail to demonstrate safety and efficacy in human, despite evidence of safety and effectiveness in pre-
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Proteomics Session 1 Introduction. Some basic concepts in biology and biochemistry.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
NCI Initiatives to Develop Non-Clinical Models for Pediatric Oncology Malcolm A. Smith, MD, PhD 17 March 2004.
Multi-scale network biology model & the model library 多尺度网络生物学模型 -- 兼论模型库的建立与应用 Jianghui Xiong 熊江辉
Drug Discovery &Development
Can Drug Discovery Research be Done At An Undergraduate Institution?
ATOM Accelerating Therapeutics for Opportunities in Medicine
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
Biotechnology Objectives: At the end of this lecture we will be able to identify and describe the uses of biotechnology in society.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Figure 2 Multiscale modelling in oncology
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Insight into the Pharmaceutical Industry
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Benjamin Wooden, Nicolas Goossens, Yujin Hoshida, Scott L. Friedman 
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Drug Design and Drug Discovery
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Tyrosine kinase inhibitors
Prof. Jean-Marc Nabholtz, MD, MSc Chairman
LiSyM- Pillar II Chronic liver disease progression
Presentation transcript:

PREDICT

The BTS systems biology software platform The BTS Systems Biology software platform allows the integration of dynamic models at the cellular scale into whole-body PBPK models at the organism level. Thereby, multiscale models can be constructed which simultaneously consider the distribution of compounds and the resulting cellular response at the tumor level. 01.01.2019 Title

Project Plan PREDICT molecular and cellular level tumor/organ identification of new drugable targets optimization of efficacy & ADME-Tox animal safety First in Man dose human safety efficacy vs. placebo efficacy vs. benchmark Target identification & validation Lead identification & optimization Preclinical development Clinical phase I Clinical phase II Clinical phase III molecular and cellular level tumor/organ whole body scFv-TRAIL PREDICT reference drug A literature reference drug B • Project Application ‘PREDICT’, Towards Predicting Effective Treatment of Cancer, Lars Küpfer

Milestones and deliverables scFv-TRAIL refinement of protein PBPK model and compartementalized tumor model develop concepts for cross-species extrapolation of biologicals (incl. gene expression data) model and simulate experimental data of project with a murine multiscale model (incl molecular, cell and tumor level) comparative assessment candidates (e.g., imatinib, sorafenib, sunitinib or gefitinib) identify suitable (pre-)clinical trial data based on literature research develop multiscale PK/PD models (incl. modules from project partners where reasonable) develop model-based concepts for clinical translation by posterior analysis of existing trial results (incl. cell lines, xenografts and patients) evaluate potential of therapeutic protein used in PREDICT in hypothetical FIM studies 01.01.2019 Title

A New Compartmental Gastro-Intestinal Tract Model Detailed mechanistic description of the GI tract including physiological representation of gut lumen and mucosa allows for a more detailed implementation and improved translation of several processes multiple applications can transit at any time active processes such as glucose transporters (apical and basolateral) representation of food to account for food effect mucosal blood flow provides physiological absorption into the blood stream transit and absorption of oral drugs entero-hepatic cycling Thelen et al., 2011a,b,c 15 June, 2011 REACTION Review, Brussels